Drawing for RUTHINIUM

USPTO serial 99318657

RUTHINIUM

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ADEBAYO, OMOLAYO E.
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with RUTHINIUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,143*

Plus Government fees of $1,050

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jayme M. Torelli

Jayme M. Torelli Hoffman Warnick LLC6 Tower Pl1st FloorAlbany, NY 12203

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer application software for mobile phones, namely, software for accessing and utilizing an online retail platform, requesting medical prescriptions, medical evaluations, connecting with medical providers, receiving information about personal care and healthcare related products and services, ordering personal care and healthcare related products and services and for managing such ordersACTIVE—
035Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Retail pharmacy services; Mail order pharmacy services; Institutional retail pharmacy services; Specialized retail pharmacy services for patients with particular medical conditionsACTIVE—
036Pharmacy benefit management services; Financial administration of pharmacy reimbursement programs and services; Insurance administration of prescription drug benefit plans; Pharmaceutical benefit management services; Reimbursement payment processing in the field of prescription drug claims; Insurance claims processing in the field of prescription drug claimsACTIVE—
038Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction and payment communications between healthcare providers and payersACTIVE—
042Providing on-line, non-downloadable, Internet-based software application for medical billing for physicians and health care institutionsACTIVE—
044Prescription refill reminder services; Charitable services, namely, patient assistance program to provide drugs free of charge to low-income patients without prescription drug coverage; Interactive medical monitoring and alert service for reminding clients of medicinal dosage, allergic sensitivity, and prescription refills for medical treatment purposes; Telemedicine services; Pharmaceutical advice; Medical and pharmaceutical consultation; Preparation of prescriptions by pharmacists; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical information to patients in the form of reports in the field of diseases and disorders treatable with pharmaceutical preparations, rare diseases, pharmaceuticals, prescription drugsACTIVE—
045Providing information about legal eligibility requirements for government medical and pharmaceutical programsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 3, 2026EX1GSOU EXTENSION 1 GRANTED—
Aug 3, 2026EXT1SOU EXTENSION 1 FILED—
Aug 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 17, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 20, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 20, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 14, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 18, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 17, 2025DOCKASSIGNED TO EXAMINER—
Dec 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 4, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance